Response to chemotherapy and prognosis in metastatic colorectal cancer with deficient mismatch repair

被引：0
|
作者：
Alex, A. [1 ]
Siqueira, S. [1 ]
Coudry, R. [2 ]
Santos, J. [1 ]
Alves, M. [1 ]
Hoff, P. [2 ]
Riechelmann, R. [1 ]
机构：
[1] ICESP, Sao Paulo, Brazil
[2] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-002
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair
    Alex, Alexandra Khichfy
    Siqueira, Sheila
    Coudry, Renata
    Santos, Juliana
    Alves, Michel
    Hoff, Paulo M.
    Riechelmann, Rachel P.
    CLINICAL COLORECTAL CANCER, 2017, 16 (03) : 228 - 239
  • [2] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Quiroga, Dionisia
    Lyerly, H. Kim
    Morse, Michael A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
  • [3] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Dionisia Quiroga
    H. Kim Lyerly
    Michael A. Morse
    Current Treatment Options in Oncology, 2016, 17
  • [4] Association of colorectal cancer intrinsic subtypes with prognosis, chemotherapy response, deficient mismatch repair, and epithelial to mesenchymal transition (EMT)
    Simon, Iris
    Roepman, Paul
    Schlicker, Andreas
    Tabernero, Josep
    Majewski, Ian
    Aguado, Victor Moreno
    Chresta, Christine M.
    Rosenberg, Robert
    Nitsche, Ulrich
    Macarulla, Teresa
    Capella, Gabriel
    Salazar, Ramon
    Orphanides, George
    Wessels, Lodewyk F. A.
    Bernards, Rene
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Association of colorectal cancer intrinsic subtypes with prognosis, chemotherapy response, deficient mismatch repair, and epithelial to mesenchymal transition (EMT).
    Salazar, Ramon
    Roepman, Paul
    Tabernero, Josep
    Schlicker, Andreas
    Majewski, Ian
    Moreno, Victor
    Rosenberg, Robert
    Kopetz, Scott
    Wessels, Lodewyk F. A.
    Bernards, Rene
    Simon, Iris
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Response to pembrolizumab in patients with mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
    Leal, Alexis Diane
    Paludo, Jonas
    Finnes, Heidi D.
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer
    Ryan, E. J.
    Creavin, B.
    Khaw, Y. L.
    Kelly, M. E.
    Mohan, H. M.
    Geraghty, R.
    Ryann, E. J.
    Kennelly, R.
    Hanly, A.
    Martin, S. T.
    Fennelly, D.
    McDermott, R.
    Gibbons, D.
    O'Connell, P. R.
    Sheahan, K.
    Winter, D. C.
    BJS OPEN, 2018, 2 (06): : 456 - 463
  • [8] Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
    Taieb, Julien
    Svrcek, Magali
    Cohen, Romain
    Basile, Debora
    Tougeron, David
    Phelip, Jean-Marc
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 136 - 157
  • [9] Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer.
    Stemmer, Amos
    Strauss, Gal
    Halpern, Naama
    Beller, Tamar
    Golan, Talya
    Margalit, Ofer
    Shacham-Shmueli, Einat
    Boursi, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 254 - 254
  • [10] Prognosis in DNA mismatch repair deficient colorectal cancer: Are all MSI tumours equivalent?
    Clark A.J.
    Barnetson R.
    Farrington S.M.
    Dunlop M.G.
    Familial Cancer, 2004, 3 (2) : 85 - 91
12345